Literature DB >> 28697556

proBDNF Accelerates Brain Amyloid-β Deposition and Learning and Memory Impairment in APPswePS1dE9 Transgenic Mice.

Jia Chen1,2, Tao Zhang1, Shusheng Jiao1, Xinfu Zhou3, Jinhua Zhong3, Yanjiang Wang1, Juan Liu1, Juan Deng1, Shuiping Wang2, Zhiqiang Xu1.   

Abstract

BACKGROUND: Alzheimer's disease (AD) is pathologically known for the amyloid-β (Aβ) deposition, neurofibrillary tangles, and neuronal loss in the brain. The precursor of brain-derived neurotrophic factor (proBDNF) before proteolysis has opposing functions to its mature form in neuronal survival and neurite growth. However, the role of proBDNF in the pathogenesis of AD remains unclear.
OBJECTIVE: To investigate the effects of proBDNF on neurons in vitro, and on learning and memory impairment and brain Aβ production in a transgenic AD mouse model (APPswePS1dE9).
METHODS: We here examined the effects of proBDNF on the viability (MTT assay) and neurite growth (morphologic measurement) of the primary neurons in vitro. After the intracerebroventricular injection of adeno-associated virus-proBDNF (AAV-proBDNF), we then investigated the learning and memory impairment (Morris water maze) and Aβ deposition in the brains of the AD mice.
RESULTS: The results showed that proBDNF could inhibit neuronal viability and neurite growth in vitro, enhance Aβ levels, and accelerate its deposition in the brain, which was consistent with the learning and memory impairment of AD mice, likely dependent on the membrane receptor of p75NTR.
CONCLUSIONS: Our findings suggest that proBDNF may exert a crucially negative effect during AD pathogenesis andprogression.

Entities:  

Keywords:  Alzheimer’s disease; amyloid-β; learning and memory; neurotoxicity; p75NTR; proBDNF

Mesh:

Substances:

Year:  2017        PMID: 28697556     DOI: 10.3233/JAD-161191

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  8 in total

Review 1.  Adeno-associated virus-based Alzheimer's disease mouse models and potential new therapeutic avenues.

Authors:  Lars M Ittner; Matthias Klugmann; Yazi D Ke
Journal:  Br J Pharmacol       Date:  2019-04-23       Impact factor: 8.739

Review 2.  Born to Protect: Leveraging BDNF Against Cognitive Deficit in Alzheimer's Disease.

Authors:  Lucia Caffino; Francesca Mottarlini; Fabio Fumagalli
Journal:  CNS Drugs       Date:  2020-03       Impact factor: 5.749

Review 3.  Amyloid beta soluble forms and plasminogen activation system in Alzheimer's disease: Consequences on extracellular maturation of brain-derived neurotrophic factor and therapeutic implications.

Authors:  Francesco Angelucci; Kateřina Čechová; Richard Průša; Jakub Hort
Journal:  CNS Neurosci Ther       Date:  2018-11-06       Impact factor: 5.243

4.  Serum Levels of FGF21, β-Klotho, and BDNF in Stable Coronary Artery Disease Patients With Depressive Symptoms: A Cross-Sectional Single-Center Study.

Authors:  Yeshun Wu; Zijun Chen; Jiahao Duan; Kai Huang; Bin Zhu; Ling Yang; Lu Zheng
Journal:  Front Psychiatry       Date:  2021-01-21       Impact factor: 4.157

5.  Plasma Amyloid-β dynamics in late-life major depression: a longitudinal study.

Authors:  Nunzio Pomara; Davide Bruno; Chelsea Reichert Plaska; Jaime Ramos-Cejudo; Ricardo S Osorio; Anilkumar Pillai; Bruno P Imbimbo; Henrik Zetterberg; Kaj Blennow
Journal:  Transl Psychiatry       Date:  2022-07-28       Impact factor: 7.989

6.  Overexpression of Brain- and Glial Cell Line-Derived Neurotrophic Factors Is Neuroprotective in an Animal Model of Acute Hypobaric Hypoxia.

Authors:  Maria S Gavrish; Mark D Urazov; Tatiana A Mishchenko; Victoria D Turubanova; Ekaterina A Epifanova; Victoria G Krut'; Alexey A Babaev; Maria V Vedunova; Elena V Mitroshina
Journal:  Int J Mol Sci       Date:  2022-08-27       Impact factor: 6.208

Review 7.  Neuro-Immuno-Gene- and Genome-Editing-Therapy for Alzheimer's Disease: Are We There Yet?

Authors:  Sudhanshu P Raikwar; Ramasamy Thangavel; Iuliia Dubova; Mohammad Ejaz Ahmed; Pushpavathi Govindhasamy Selvakumar; Duraisamy Kempuraj; Smita Zaheer; Shankar Iyer; Asgar Zaheer
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

8.  Lower brain-derived neurotrophic factor levels are associated with age-related memory impairment in community-dwelling older adults: the Sefuri study.

Authors:  Yoshito Mizoguchi; Hiroshi Yao; Yoshiomi Imamura; Manabu Hashimoto; Akira Monji
Journal:  Sci Rep       Date:  2020-10-05       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.